The Evolution of PolyProx Therapeutics
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Karen Scrivener.
Laura Itzhaki’s talk will focus on a new technology that PolyProx Therapeutics has developed to harness the cell’s internal quality-control machinery. Their approach shortcuts cell signals to redirect the machinery to dispose of disease-associated proteins. In 2019, PolyProx Therapeutics secured seed financing to develop drug candidates exploiting this technology.
This talk is part of the Sensors CDT seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|